SAN FRANCISCO–(BUSINESS WIRE)–Grove AI, a next-generation clinical trial management and intelligence company, today announced a $4.9 million seed fundraise led by A*, with participation from Afore Capital, LifeX Ventures, Pear VC, Upfront Ventures, and industry-leading angels. This investment will allow Grove to continue scaling its team and product to redefine clinical trials from siloed operations into participant-centered ecosystems driven by real-time data. Despite their vital role in adv